Attached files

file filename
10-K - 10-K - ALNYLAM PHARMACEUTICALS, INC.alny-20191231.htm
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC.exhibit-322.htm
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC.exhibit-321.htm
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC.exhibit-312.htm
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC.exhibit-311.htm
EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC.exhibit-231.htm
EX-10.50 - EX-10.50 - ALNYLAM PHARMACEUTICALS, INC.exhibit-1050.htm
EX-10.10 - EX-10.10 - ALNYLAM PHARMACEUTICALS, INC.exhibit-1010.htm
EX-4.2 - EX-4.2 - ALNYLAM PHARMACEUTICALS, INC.exhibit-42.htm
EX-3.2 - EX-3.2 - ALNYLAM PHARMACEUTICALS, INC.exhibit-32.htm

EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
 
Name Ownership Percentage Jurisdiction of Organization
Alnylam U.S., Inc. 100% Delaware
Alnylam Securities Corporation

100%

Massachusetts
Sirna Therapeutics, Inc.

100%

Delaware
Alnylam Austria GmbH

100%

Austria
Alnylam Belgium BVBA

100%

Belgium
Alnylam Brasil Farmaceutica Ltda

99%

Brazil
Alnylam (Bermuda) Ltd. 100% Bermuda
Alnylam Canada ULC

100%

Canada
Alnylam France SAS 100% France
Alnylam Europe AG

100%

Germany
Alnylam Germany GmbH

100%

Germany
Alnylam Italy Srl 100% Italy
Alnylam Japan KK

100%

Japan
Alnylam Netherlands BV

100%

Netherlands
Alnylam Pharmaceuticals Spain SL

100%

Spain
Alnylam Sweden AB

100%

Sweden
Alnylam Switzerland GmbH

100%

Switzerland
Alnylam Taiwan Co., Ltd.

100%

Taiwan
ALNYPT Unipessoal Lda

100%

Portugal
Alnylam UK Limited

100%

United Kingdom
Alnylam Czech s.r.o.

100%

Czech Republic